Bank of New York Mellon Corp Has $728,000 Stock Position in Quantum-Si incorporated (NASDAQ:QSI)

Bank of New York Mellon Corp lifted its stake in Quantum-Si incorporated (NASDAQ:QSI) by 21.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 269,807 shares of the company’s stock after purchasing an additional 47,400 shares during the period. Bank of New York Mellon Corp owned 0.19% of Quantum-Si worth $728,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in QSI. Geode Capital Management LLC boosted its holdings in Quantum-Si by 6.7% during the third quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after buying an additional 145,091 shares during the last quarter. Barclays PLC raised its position in shares of Quantum-Si by 210.5% in the 3rd quarter. Barclays PLC now owns 196,826 shares of the company’s stock valued at $173,000 after acquiring an additional 133,438 shares during the period. Rhumbline Advisers boosted its stake in Quantum-Si by 3.7% during the 4th quarter. Rhumbline Advisers now owns 148,946 shares of the company’s stock worth $402,000 after acquiring an additional 5,298 shares during the last quarter. SG Americas Securities LLC boosted its stake in Quantum-Si by 12.4% during the 4th quarter. SG Americas Securities LLC now owns 67,588 shares of the company’s stock worth $182,000 after acquiring an additional 7,470 shares during the last quarter. Finally, XTX Topco Ltd grew its holdings in Quantum-Si by 81.3% during the third quarter. XTX Topco Ltd now owns 43,812 shares of the company’s stock valued at $39,000 after purchasing an additional 19,651 shares during the period. 39.90% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $3.34, for a total value of $11,710,931.78. Following the sale, the director now owns 1,250,000 shares in the company, valued at approximately $4,175,000. The trade was a 73.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jeffrey Alan Hawkins sold 23,707 shares of the firm’s stock in a transaction that occurred on Friday, March 21st. The stock was sold at an average price of $1.39, for a total transaction of $32,952.73. Following the transaction, the chief executive officer now directly owns 2,646,716 shares of the company’s stock, valued at $3,678,935.24. This represents a 0.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 3,542,917 shares of company stock worth $11,761,875 over the last ninety days. Company insiders own 30.04% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on QSI. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a report on Wednesday, March 5th. National Bankshares set a $3.65 price objective on Quantum-Si in a research note on Wednesday, March 5th. Finally, HC Wainwright reiterated a “buy” rating and set a $5.50 target price on shares of Quantum-Si in a report on Tuesday, January 14th.

Quantum-Si Stock Performance

Shares of QSI stock opened at $1.39 on Thursday. Quantum-Si incorporated has a 52 week low of $0.61 and a 52 week high of $5.77. The company’s 50 day moving average price is $1.75 and its two-hundred day moving average price is $1.49. The company has a market capitalization of $254.56 million, a P/E ratio of -2.17 and a beta of 2.75.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.